To evaluate the in-vivo safety & efficacy of a Skin Care regime in terms improvement in skin brightening, skin hydration, skin smoothness, skin pH balance and skin water barrier function on healthy female subjects. - NI

DPKA Universal Consumer Ventures Private. Limited.0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1.Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
•2.Having refused to give her assent by signing the consent form
•3.Taking part in another study liable to interfere with this study
•4.Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area
•5.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less
•than 6 months)
•6.Having a progressive asthma (either under treatment or last fit in the last 2 years)
•7.Being epileptic
•8.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
•9.Having cutaneous hypersensitivity
•10.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic
•products or food products or to latex
•11.Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes
•(the only medication permitted is paracetamol)
•12.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6
•13.Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit

发起方

DPKA Universal Consumer Ventures Private. Limited.